Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-25-054289
Filing Date
2025-06-13
Accepted
2025-06-13 16:06:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7077
  Complete submission text file 0001213900-25-054289.txt   8988
Mailing Address 865 SPRING STREET WESTBROOK ME 04092
Business Address 865 SPRING STREET WESTBROOK ME 04092 615-939-9004
Synergy CHC Corp. (Subject) CIK: 0001562733 (see all company filings)

EIN.: 990379440 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-88542 | Film No.: 251046514
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)

Mailing Address 3400 BOULEVARD DE MAISONNEUVE WEST SUITE 1055 MONTREAL A8 H3Z 3B8
Business Address 3400 BOULEVARD DE MAISONNEUVE WEST SUITE 1055 MONTREAL A8 H3Z 3B8 5144844483
Knight Therapeutics Inc (Filed by) CIK: 0001756235 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A